However, by comparing the effect of Bcl6 on HCC progression in immunocompetent mice (Fig. 2) and immune-deficient mice (Fig. 5a, b), it is reasonable to conclude that the effect of BCL6 on HCC progression through immune microenvironment is much more prominent than its effect on cancer cell growth. The gene discussed is BCL6; the disease is cancer.